Medpace has the global reach to conduct biopharmaceutical and medical device studies around the world.
We deliver custom solutions specific to your needs on six continents. Projects are facilitated through regional
offices located throughout Europe, North America, Asia, Australia, South Africa, and the Americas, with staff
and offices continually added throughout the world. Integrated clinical trial services
from our wholly-owned business units provide efficient global trial conduct from discovery to post marketing. These integrated companies
include a Phase I Unit, Central Laboratory, Imaging Core Lab, Cardiovascular Core Lab, and Bioanalytical Lab.
Medpace experts have a deep understanding of local language,
culture, and processes, creating better relationships with investigators and improved trial execution. They have greater access
to the country patient populations for faster enrollment timelines and lower costs.
The Medpace expanding global footprint is interconnected through ClinTrak® —an innovative
suite of clinical study management technologies—which gives sponsors and study managers real-time access to critical study data that
supports project decisions on a global level.